19
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Gene Response of Human Skin Fibroblasts to Urokinase-and Tissue-Type Plasminogen Activators

, , , &
Pages 249-268 | Received 03 May 1999, Accepted 22 Oct 1999, Published online: 11 Jul 2009

References

  • Anichini E., Fibbi G., Pucci M., Caldini R., Chevanne M., Del Rosso M. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor. Exp. Cell Res. 1994; 213: 438–448
  • Barlati S. Plasminogen activators and fibronectin fragments in tumor growth and signal transduction. Bull. Inst. Pasteur. 1994; 92: 269–275
  • Blasi F. u-PA. u-PAR, PAI-I: Key intersection of proteolytic, adhesive and chemotactic highways'?. Immunol. Today 1997; 18: 415–417
  • Blasi F. The urokinase receptor. A cell surface, regulated chemokine. APMIS 1999; 107: 96–101
  • Blasi F., Conese M., Mffler L. B., Pedersen N., Cavallaro U., Cubellis M. V., Fazioli F., Hernandez-Marrero L., Limongi P., Muñoz-Canoves P., Resnati M., Rittinen L., Sidenius N., Soravia E., Soria M. R., Stoppelli M. P., Talarico D., Teesalu T., Valcamonica S. The urokinase receptor structure, regulation and inhibitor-mediated internalization. Fibrinolysis 1994; 8: 182–188
  • Bohuslav J., Horejsi V., Hansmann C., Stockl J., Weidle U. H., Majdic O., Bartke I., Knapp W., Stockinger H. Urokinase plasminogen activator receptor. β2-integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 1995; 181: 1381–1390
  • Caccia P., Nitti G., Cletini O., Pucci P., Ruoppolo M., Bertolero F., Valsasina B., Roletto F., Cristiani C., Cauet G., Sarmientos P., Malorni A., Marino G. Stabilization of recombinant human basic fibroblast growth factor by chemical modifications of cysteine residues. Eur. J. Biochem. 1992; 204: 649–655
  • Chomezynsky P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem. 1987; 162: 156–159
  • Danø Behrendt N., Brunner N., Ellis V., Ploug M., Pyke M. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8(1)189–203
  • Dear A. E., Medcalf R. L. The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule. Eur. J. Biochem. 1998; 252: 185–193
  • De Petro G., Copeta A., Barlati S. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp. Cell Res. 1994; 213: 286–294
  • De Petro G., Tavian D., Copeta A., Portolani N., Giulini S. M., Barlati S. Expression of urokinase type plasminoge activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. Cancer Research 1998; 58: 2234–2239
  • Duffy M. J. Urokinase-type plasminogen activator and malignancy. Fibrinolysis 1993; 7: 295–302
  • Dumler I., Petri T., Schleumng W. D. Interaction of urokinase-type plasminogen activator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS 1993; 322: 37–40
  • El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1. a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825
  • Facchini L. M., Penn L. The molecular role of Mycin growth and transformation: Recent discoveries lead to new insights. FASEB J. 1998; 12: 633–651
  • Fazioli F., Blasi F. Urokinase-type plasminogen activator and its receptor: New targets for anti-metastatic therapy?. Trends Pharmacol. Sci. 1994; 15: 25–29
  • Fischer K., Lutz V., Wilhelm O., Schmitt M., Graeff H., Heiss P., Nishiguchi T., Harbeck N., Kessler H., Luther T., Magdolen V., Reuning U. Urokinase induces proliferation of human ovarian cancer cells: Characterization of structural elements required for growth factor function. FEBS Letters 1998; 438: 101–105
  • Fukao H., Matsuo O. Analysis of tissue-type plasminogen activator receptor (t-PAR) in human endothelial cells. Seminars in Thrombosis and Hemostasis 1998; 24: 269–273
  • Gailit J., Clark R. A.F. Wound repair in thecontext of extracellular matrix. Current Opinion in Cell Biology 1994; 6: 717–725
  • Harris T. J.R. Second-generation plasminogen activators. Protein Eng. 1982; 1: 449–458
  • Hawker J. R., Granger H. J. Tyrosine kinase inhibitors impair fibroblasts growth factor signalling in coronary endothelial cells. Am. J. Physiol. 1994; 266: H107–H120
  • He C.-J., Rebibou J.-M., Peraldi M.-N., Meulders Q., Rondeau E. Growth factor-like effect of urokinase type plasminogen activator in human renal cells. Biochem. Biophys. Res. Commun. 1991; 176: 1408–1416
  • Herbert J. M., Lamarche I., Carmeliet P. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. J. Biol. Chem. 1997; 272: 23585–23591
  • Herbert J. M., Lamarche I., Prabonnaud V., Dol F., Gauthler T. Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J. Biol. Chem. 1994; 269: 3076–3080
  • Herschman H. R. Primary response genes induced by growth factors and tumor promoters. Ann. Rev. Biochem. 1991; 60: 281–319
  • Irving J., Feng J., Wistrom C., Pikaart M., Vileeponteau B. An altered repertoire of fos/jun (AP1) at the onset of replicative senescence. Exp. Cell. Res. 1992; 202: 161–166
  • Iyer V. R., Eisen M. B., Ross D. T., Sculer G., Moore T., Lee J. C.F., Trent J. M., Staudt L. M., Hudson J., Jr., Boguski M. S., Lashkari D., Shalon D., Botstein D., Brown O. P. The transcriptional program in the response of human fibroblasts to serum. Science 1999; 283: 83–87
  • Kelly K., Cochran B. H., Stiles C. D., Leder P. Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet derived growth factors. Cell 1963; 35: 603–610
  • Kirchheimer J. C., Wojta J., Christ G., Binder B. R. Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J. 1987; 1: 125–128
  • Kirchheimer J. C., Wojta J., Christ G., Binder B. R. Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line. Proc. Natl. Acad. Sci. USA 1989; 86: 5424–5428
  • Kirchheimer J. C., Wojta J., Christ G., Hienert G., Binder B. R. Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cells. Carcinogenesis 1988; 9: 2121–2123
  • Ko Y., Totze G., Schiermeyer B., Zeitler H., Schmitz U., Vetter H., Sachinidis A. Reverse transcriptase-polymerase chain reaction (RT-PCR): a sensitive method to examine basic fibroblast growth factor-induced expression of the early growth response gene-1 (egr-1) in human umbilical arterial endothelial cells. Molecular and Cellular Probe 1995; 9: 215–222
  • Konakova M., Hucha F., Schleuning W. D. Downstream targets of urokinase-type plasminogen activator-mediated signal transduction. Eur. J. Biochem. 1998; 253: 421–429
  • Koopman J. P., Slomp J., de Bart A. C.W., Quax P. H.A., Verheijen J. H. Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor. J. Biol. Chem. 1998; 273: 33 267–33 272
  • Lamb P., Crawford L. Characterization of the human p53 gene. Mol. Cell Biol. 1986; 6: 1379–1385
  • Loskutoff D. J., Linders M., Keijer J., Veerman H., van Heeikhizen H., Pannekoek H. Structure of the human plasminogen activator inhibitor 1 gene: Nonrandom distribution of introns. Biochemistry 1987; 26: 3763–3768
  • Marchina E., Barlati S. Degradation of human plasma and extracellular matrix fibronectin by tissue-type plasminogen activator and urokinase. Int. J. Biochem. Cell Biol. 1996; 28: 1141–1150
  • Mordret G. MAP kinase kinase: A node connecting multiple pathways. Biol. Cell 1993; 79: 193–207
  • Moro L., Colombi M., Molinari M., Tosatti P., Barlati S. Study of fibronectin mRNA in human laryngeal and ectocervical carcinomas by in situ hybridization and image analysis. In. J. Cancer 1992; 51: 692–697
  • Ny I., Elgh F., Lund B. The structure of the human tissue-type plasminogen activator gene: Correlation of intron and exon structures to functional and structural domains. Proc. Natl. Acad. Sci. USA 1984; 81: 5355–5359
  • Ohtani H. Stromal reaction in cancer tissue: Pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions. Pathology International 1998; 48: 1–9
  • Olson D., Pöllänen J., Høyer-Hansen G., Ronne E., Sakaguchi K., Wun T. C., Appella E., Danø K., Blasi F. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J. Biol. Chem. 1992; 267: 9129–9133
  • Palfree R. G.E. The urokinase-typeplasminogenactivator rcceptor is a member of the Ly-6 superfamily. Immunol. Today 1991; 12: 170
  • Patthy L. Evolution of the proteases of blood coagulation and fibrinolysis by assembly of modules. Cell 1985; 41: 657–663
  • Pöllänen J., Stephensen R. W., Vaheri A. Directed plasminogen activation at the surface of normal and malignant cells. Adv. Cancer Res. 1991; 57: 273–328
  • Pöllänen J., Saksela O., Salonen E. M., Andreasen P., Nielsen L., Danø K., Vaheri A. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J. Cell Biol. 1987; 104: 1085–1096
  • Rabbani S. A., Mazar A. P., Bernier S. M., Haq M., Bolivar I., Henkin J., Goltzman D. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 1992; 267: 14151–14156
  • Redlitz A., Plow E. F. Receptors for plasminogen and t-PA: An update. Baillere's Clin. Haematol. 1995; 8: 313–325
  • Riccio A., Grimaldi G., Verde P., Sebastio G., Boast S., Blasi F. The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res. 1985; 130: 2759–2771
  • Rifkin D. B. Cross-talk among proteases and matrix in the control of growth factor action. Fibrinolysis and Proteolysis 1997; 1: 3–9
  • Seger R., Seger D., Lozeman F. J., Ahn N. G., Gravest L. M., Campbell J. S., Ericson L., Harrylock M., Jensen A. M., Krebs E. G. Human T-cell mitogen activated protein kinase kinase are related to yeast signal transduction kinases. J. Biol. Chem. 1992; 267: 25628–25631
  • Shetti S., Kumar A., Johnson A. R., Idell S. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor. Antisense Research and Development 1995; 5: 307–314
  • Shetti S., Kumar A., Johnson A. R., Pueblitz S., Holiday D., Raghu G., Idell S. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am. J Respir. Cell Mol. Biol. 1996; 15: 78–87
  • Shimokado K., Umezaga K., Ogata J. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells. Exp. Cell Res. 1995; 220: 266–273
  • Stahl A., Mueller B. M. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J. Cell Biol. 1995; 129: 335–344
  • Takada A., Takada Y. Plasminogen activators: possible roles in cell proliferation. Dermatologica 1989; 179: 77–83
  • Van Straaten F., Muller R., Curran T., Van Beveren C., Verma I. M. Complete nucleotide sequence of a human c-onc gene: Deduced amino acid sequence of the human c-fos protein. Proc. Natl. Acad. Sci. USA 1983; 80: 3183–3187
  • Vassalli J. D. The urokinase receptor. Fibrinolysis 1994; 8: 172–181
  • Wang J. Hepatitis virus integration inacyclin A gene in a hepatocellular carcinoma. Nature 1990; 343: 555–557
  • Wang A. M., Doyle V. M., Mark D. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 1989; 86: 9717–9721
  • Watson D. K., Psallidopulos M. C., Samuel K. P., Dalla Favera R., Papas T. S. Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product. Proc. Natl. Acad. Sci. USA 1983; 80: 3642–3645
  • Wei Y., Lukashev M., Simon D. I., Bodary S. C., Rosenberg S., Doyle M. V., Chapman H. A. Regulation of integrin function by the urokinase receptor. Science 1996; 273: 1551–1555

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.